CCRN stock icon

Cross Country Healthcare
CCRN
Market cap $432M

12.78 USD
-0.11
0.85%
At close Oct 3, 4:00 PM EDT
After hours
12.78
+0.00
0%
1 day
-0.85%
5 days
-5.96%
1 month
-12.65%
3 months
-6.17%
6 months
-28.56%
Year to date
-45.2%
1 year
-48.9%
5 years
29.88%
 

About: Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Employees: 2,300

0
Funds holding %
of 6,728 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

409% more call options, than puts

Call options by funds: $163K | Put options by funds: $32K

5.14% less ownership

Funds ownership: 104.31% [Q1] → 99.17% (-5.14%) [Q2]

7% less funds holding

Funds holding: 173 [Q1] → 161 (-12) [Q2]

11% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 65

30% less capital invested

Capital invested by funds: $678M [Q1] → $477M (-$201M) [Q2]

41% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 29

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$17
33%
upside
Avg. target
$18
41%
upside
High target
$19
49%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
Barrington Research
Kevin Steinke
53% 1-year accuracy
16 / 30 met price target
49%upside
$19
Outperform
Maintained
8 Aug 2024
Truist Securities
Tobey Sommer
92% 1-year accuracy
34 / 37 met price target
33%upside
$17
Hold
Maintained
1 Aug 2024

Financial journalist opinion

Charts implemented using Lightweight Charts™